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Abstract
Introduction: Cardiac metastasis of urothelial carcinoma is a very rare but clinically important complication. Most
cardiac metastases are asymptomatic; symptoms from cardiac metastasis were seen in advanced stage and many of
these cases were reported to have a poor prognosis. So it is important to find asymptomatic cardiac metastasis and
to start chemotherapy early in order to improve the patient’s prognosis.
Case presentation: A 73-year-old Asian man was referred to our hospital because of a right ventricular tumor. He had
a history of left ureteral cancer 9 years ago. In screening echocardiography for paroxysmal atrial fibrillation, a low
echogenic tumor was detected in his right ventricular apex, and characteristic ST segment elevation was detected in
electrocardiography. An 18F-fluorodeoxyglucose positron emission tomography revealed abnormal uptake in his right
ventricular apex tumor and prostate, and a biopsy of the prostatic tumor showed urothelial carcinoma cells. He
received systemic gemcitabine, paclitaxel and cisplatin chemotherapy for the urothelial carcinoma, and the cardiac
tumor size was reduced temporarily. Finally, he died of multiple organ failure 16 months after his first admission, but
his survival period was relatively longer than previous reports.
Conclusions: We experienced a case of a metastatic cardiac tumor from urothelial carcinoma. We found asymptomatic
cardiac metastasis by screening echocardiography and electrocardiography. Our patient received systemic chemotherapy
and his survival period was relatively longer than previous reports. Electrocardiography and echocardiography may be
useful to find asymptomatic cardiac metastasis of neoplasms.
Keywords: Cardiac metastasis, Echocardiography, Urothelial carcinoma
Introduction
Cardiac metastasis from urothelial carcinoma is very un-
common. To the best of our knowledge, only a small
number of cases were reported and most of the cases
had poor prognosis. We present a case of a metastatic
cardiac tumor from urothelial cell carcinoma that was
incidentally detected by screening echocardiography. We
treated the patient with systemic chemotherapy and suc-
ceeded in temporarily reducing the tumor size. The pa-
tient had 16 months of survival from diagnosis of
cardiac metastasis, which is a longer period than other
cases reported in the literature.
Case presentation
A 73-year-old Asian man was referred to our hospital
because of a right ventricular tumor. He had a history of
left ureteral cancer, and he had undergone nephroureter-
ectomy of his left kidney 9 years ago and transurethral
resection of a bladder tumor (TUR-Bt) for intravesical
recurrence. After four histories of TUR-Bt, no evidence
of cancer recurrence was found for a period of 6 years.
However, echocardiography for cardiac screening of par-
oxysmal atrial fibrillation revealed a low echogenic
tumor in his right ventricle (RV), and he was admitted
to our hospital for further examination.
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The results of a physical examination were almost
within normal limits, and laboratory tests showed mild
chronic kidney disease (creatinine level of 1.22 mg/dl
and blood urea nitrogen level of 21 mg/dl) and a mildly
elevated brain natriuretic peptide level (178 pg/ml). In
electrocardiography (ECG), mild ST-segment elevation
and T wave inversion were revealed in V1–3 (Fig. 1).
Transthoracic echocardiography revealed a 35×35 mm
low echogenic tumor that was invading the myocardium
of the apex of his RV, and the border of the tumor
was poorly defined. There was a small amount of
pericardial effusion and no detectable valvular abnormality
(Fig. 2a, b).
We suspected the tumor to be a metastasis from
urothelial cancer based on its echocardiographical fea-
tures and the patient’s past history. We tried to detect
the primary lesion by 18F-fluorodeoxyglucose positron
emission tomography (FDG-PET), and it showed abnor-
mal FDG uptake in his RV apex tumor and prostate
(Fig. 3a). Pelvis magnetic resonance imaging (MRI) re-
vealed another lesion invading his prostate, and a biopsy
of the prostate lesion showed carcinoma cells suspected
to be from the urothelial carcinoma with squamous dif-
ferentiation. Although the tumor was localized on his
RV apical wall, and the risk of RV apical wall perforation
due to cardiac biopsy was therefore considered to be
relatively high, we recommended surgical or transvenous
biopsy of the RV tumor for definite diagnosis of a meta-
static cardiac tumor. However, he did not wish to
undergo a biopsy.
We decided to perform systemic chemotherapy for the
urothelial carcinoma and cardiac lesion. The patient
received gemcitabine, paclitaxel and cisplatin therapy
(GTC) for the urothelial carcinoma. After two courses of
GTC therapy (75 and 50 % dose), the tumors of the
prostate and RV apex wall became smaller, and FDG up-
take of the tumors was also reduced as shown by follow-
up FDG-PET (Figs. 2c, d and 3b). We suspected the RV
tumor to be a metastatic cardiac tumor from urothelial
carcinoma without pathological analysis because chemo-
therapy for the urothelial carcinoma was also effective
for the RV tumor.
However, a new pubic bone metastasis was also re-
vealed by follow-up FDG-PET. Radiation therapy was
then performed for pubic bone metastasis (3 Gy×18
times, total 54 Gy). After the radiation therapy, chemo-
therapy was continued but the regime was changed to
gemcitabine and cisplatin (GC) because of renal dys-
function. However, after three cycles of GC chemo-
therapy (50 % dose each), lung metastasis and adrenal
gland metastasis were also detected, and chemotherapy
itself was discontinued because of renal dysfunction,
bone marrow suppression, and poor performance status.
Finally, he died from multiple organ failure 16 months
after his first admission. An autopsy was not performed
because permission could not be obtained from his family.
Discussion
According to a recent review, cardiac metastasis from a
malignant neoplasm is not rare. In past autopsy studies,
the incidences of cardiac metastasis were estimated to
range from 1.7 to 14 % in patients with cancer and from
0.7 to 3.5 % in the general population [1]. By contrast,
the incidence of primary cardiac malignant neoplasm
Fig. 1 Electrocardiography at first admission for cardiac evaluation. Heart rate was 75/minute with normal axis. However, mild ST elevation and T
inversion were detected in V1–3
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ranged from only 0.001 to 0.28 % [2]. In addition, the
incidence of cardiac metastasis is expected to increase
because of the improvement of prognosis for patients
with cancer that is associated with advances in cancer
therapeutic strategies [1].
Bussani et al. reported a large series of autopsy cases
in 2007 [2]. They examined the cases of 18,751 in-
hospital deceased patients, and they found one or more
malignant neoplasms in 7289 patients. They also found
cardiac metastasis in 662 of the patients (9.1 % of all),
Fig. 2 Transthoracic echocardiography. a, b Echocardiography before chemotherapy (a, diastolic phase; b, systolic phase): a low echogenic tumor
was detected in the right ventricle apex wall (white arrowheads). c, d Echocardiography after two courses of chemotherapy (c, diastolic phase;
d, systolic phase): right ventricle apex tumor had become smaller (white arrowheads)
Fig. 3 The patient’s 18F-fluorodeoxyglucose positron emission tomography. a His 18F-fluorodeoxyglucose positron emission tomography before
chemotherapy: abnormal uptake was detected in the right ventricle apex tumor and prostate tumor (white arrowheads). b His 18F-fluorodeoxyglucose
positron emission tomography after chemotherapy: uptake in the right ventricle apex tumor and prostate tumor was reduced
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and the most common cancers among cardiac metas-
tases were lung cancer (39.2 % of cardiac metastasis
cases from lung cancer), breast cancer (10.0 %), meso-
thelioma (9.4 %) and lymphoma/leukemia (10.0 %). It was
also shown that mesothelioma, melanoma and lung
cancer have a relatively high potential for cardiac
metastasis [2].
By contrast, cardiac metastasis from urothelial carcin-
oma is very rare. According to the autopsy study from
Bussani et al. only 12 of 307 patients with urothelial
carcinoma had cardiac metastasis [2]. In fact, to the
best of our knowledge, only a small number of cases of
symptomatic cardiac metastasis from urothelial carcin-
oma have been reported in the English literature. The
reason for the rarity of cardiac metastasis from urothe-
lial carcinoma is unclear. However, it may be due to the
metastatic pathway of urothelial carcinoma. Malignant
tumors metastasize to the heart by four alternative
pathways: direct extension, hematogenous spread, lym-
phatic spread, and intracavitary extension from the
inferior vena cava [3]. In epithelial malignancies, in-
cluding urothelial carcinoma, distal metastasis occurred
mainly by the lymphatic pathway [3]. However, in the
heart, lymphatic flow is directly from the endocardium
to the epicardium, and lymphatics drain from the heart
to the mediastinum. It is therefore speculated that
tumor cells cannot easily reach the heart without
lymphatic flow stagnating due to tumor emboli [2].
This mechanism of the lymphatic system may play an
important role in the rarity of cardiac metastasis from
urothelial carcinoma.
The prognosis of cardiac metastasis from urothelial
carcinoma is poor. Hattori et al. showed in a review of
14 cases that most patients died shortly after the original
diagnosis or first visit [4]. Systemic chemotherapy or
surgical resection of the tumor resulted in a prognosis of
relatively long survival in only a few patients [5–8]. In
our case, cardiac metastasis was detected by screening
echocardiography for paroxysmal atrial fibrillation before
the patient had any complaint, and systemic chemo-
therapy for urothelial carcinoma resulted in relatively
long survival. Thus, early detection of cardiac metastasis
and prostatic recurrence of carcinoma may have been
important for the relatively long survival of our patient.
In addition, in our case, ECG showed characteristic ab-
normality (mild ST elevation and T inversion in V1–3).
The exact cause of this ECG abnormality is unknown,
but myocardial injury of the RV apex wall attributed to
the metastatic tumor may have resulted in the ECG
abnormality. A similar ECG abnormality was reported by
Na et al. in a case of mimicking ST-segment elevation in
myocardial infarction [9]. This case suggested that new
onset ECG abnormality might provide a clue for the
diagnosis of cardiac metastasis.
Conclusions
We experienced a case of a metastatic cardiac tumor from
urothelial carcinoma. He received systemic chemotherapy
and his survival period was relatively longer than previous
reports. In metastasis to the heart, most patients are
asymptomatic, and it is therefore important to detect ECG
or echocardiographical abnormality, recognize cardiac
metastasis, and start appropriate treatment as early as
possible.
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